WEX Posts Four EPS Beats, Trades at 9x Earnings
WEX Inc. has beaten analyst EPS estimates for four consecutive quarters — and its most recent beat was the largest in the streak — yet the stock trades at just 9.1x forward earnings and sits precisely
WEX Posts Four EPS Beats, Trades at 9x Earnings
NEW YORK, September 6 —
WEX Inc. (WEX) has beaten analyst EPS estimates for four straight quarters, with the most recent beat the largest in the streak, yet the stock trades just above the sell-side consensus target of $192.4, implying analysts see nowhere left to go. Five executives read the same setup and sold $6.83 million in shares, with no purchases.
- EPS of $5.35 beat the $5.07 estimate by 5.5%, the widest margin in four consecutive quarterly beats.
- Trailing twelve-month revenue of $2.79 billion grew 14.2% year-over-year; forward P/E stands at 9.1x.
- Five insiders sold $6.83 million in shares between July 6 and September 1, 2026; zero purchases recorded.
Why 9x Does Not Add Up
WEX processes fleet payments through its Mobility segment, automates accounts payable for travel and fintech clients through Corporate Payments, and runs a health-benefits SaaS platform through Benefits. Trailing revenue reached $2.79 billion at 14.2% growth, with a 73.2% gross margin and $1.33 billion in trailing free cash flow. Prior beats in the four-quarter streak ran between 1.2% and 4.6%; the most recent 5.5% was the widest margin. Running those figures through a discounted cash flow model at 9.1x forward earnings implies the market's growth assumptions are either extremely conservative or priced for a deterioration the headline numbers have not yet confirmed.
Five Sellers, Zero Buyers
CEO Melissa Smith's September 1 trades are the most visible element in a 90-day selling pattern. She exercised options at strike prices of $104.95 and $99.69 per share, then sold 28,109 shares at $186.48 to $191.11 the same day, generating $5.34 million in proceeds per the Form 4 filings. Same-day exercise-and-sell sequences are standard tax planning, but the pattern is broader: the two COOs, Chief Risk and Compliance Officer, and Chief Accounting Officer each sold shares in open-market transactions from July 6 through August 4. Five executives recorded $6.83 million in combined sales with zero purchases in the window.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| WEX | $6.6B | 9.1x | +12.4% |
| GMED | $10.5B | 14.5x | +31.5% |
| BAND | $1.4B | 22.7x | +178.8% |
| EEFT | $2.8B | 6.2x | -18.4% |
| PCTY | $8.4B | 15.7x | -12.0% |
| PEGA | $6.1B | 14.1x | -35.0% |
Whether the Short Thesis Survives
The stock has risen 15.4% since its last earnings report, yet the sell-side consensus has not moved its target above $192.4. Short interest at 10.4% of float is a significant bearish position against a company with four straight positive surprises. The resolution comes at the next quarterly report: a fifth consecutive beat, particularly with upward guidance, would pressure analysts to revise targets higher and challenge the short thesis. A miss would validate both the single-digit multiple and the selling pattern. The number to watch: whether the beat margin holds near the recent 5.5% or narrows toward the tighter results seen earlier in the streak.
Run the free WEX Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
WEX Inc. has beaten analyst EPS estimates for four consecutive quarters — and its most recent beat was the largest in the streak — yet the stock trades at just 9.1x forward earnings and sits precisely at the analyst consensus price target, implying sell-side models see no further upside despite the momentum. Five executives have responded by selling $6.83 million in stock with zero purchases.
Sources & Filings